Shanghai Junshi Biosciences Co., Ltd. (HKG: 1877)
Hong Kong
· Delayed Price · Currency is HKD 12.98
-0.08 (-0.61%)
Nov 21, 2024, 4:08 PM HKT
Shanghai Junshi Biosciences Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -1,803 | -2,283 | -2,388 | -720.91 | -1,669 | -747.42 | Upgrade
|
| Depreciation & Amortization | 303.86 | 303.86 | 282.54 | 248.98 | 146 | 59.84 | Upgrade
|
| Other Amortization | 28.66 | 28.66 | 13.1 | 15.93 | 8.34 | 3.22 | Upgrade
|
| Loss (Gain) From Sale of Assets | -29.41 | -29.41 | -22.57 | -0.81 | -1.86 | -0.01 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.52 | 0.52 | 0.19 | 0.03 | -45.31 | -0.17 | Upgrade
|
| Loss (Gain) From Sale of Investments | 75.19 | 75.19 | 51.21 | -65.75 | 5.62 | 1.83 | Upgrade
|
| Provision & Write-off of Bad Debts | 18.34 | 18.34 | -0 | 0.36 | -0.34 | 0.05 | Upgrade
|
| Other Operating Activities | -107.97 | -178.56 | -250.42 | 7.55 | 37.77 | -32.69 | Upgrade
|
| Change in Accounts Receivable | -314.42 | -314.42 | 1,230 | -770.56 | -482.17 | -410.45 | Upgrade
|
| Change in Inventory | -32.45 | -32.45 | -136.39 | -154.82 | -166.99 | -132.2 | Upgrade
|
| Change in Accounts Payable | 262.67 | 262.67 | -505.73 | 702.33 | 685.97 | 86.02 | Upgrade
|
| Change in Other Net Operating Assets | 19.01 | 19.01 | 90.04 | 195.05 | 30.73 | 11.8 | Upgrade
|
| Operating Cash Flow | -1,454 | -2,005 | -1,776 | -605.05 | -1,456 | -1,179 | Upgrade
|
| Capital Expenditures | -848.67 | -832.57 | -393.95 | -901.77 | -580.47 | -862.26 | Upgrade
|
| Sale of Property, Plant & Equipment | 5.94 | 4.1 | 0 | 0.01 | - | 0.05 | Upgrade
|
| Cash Acquisitions | - | - | 2.22 | - | - | - | Upgrade
|
| Investment in Securities | -575.93 | -207.9 | -104.24 | -1,045 | -172.13 | -119.59 | Upgrade
|
| Other Investing Activities | 55.8 | 103.19 | 58.76 | 28.95 | 12.19 | 22.21 | Upgrade
|
| Investing Cash Flow | -1,363 | -933.19 | -437.21 | -1,918 | -740.41 | -959.59 | Upgrade
|
| Long-Term Debt Issued | - | 977.1 | 840.36 | 500 | 374.24 | 1,682 | Upgrade
|
| Long-Term Debt Repaid | - | -533.78 | -160.65 | -828.36 | -426.76 | -1,407 | Upgrade
|
| Net Debt Issued (Repaid) | 1,215 | 443.32 | 679.71 | -328.36 | -52.52 | 274.95 | Upgrade
|
| Issuance of Common Stock | - | 152.59 | 3,795 | 2,122 | 4,527 | 391.69 | Upgrade
|
| Repurchase of Common Stock | -26.89 | -26.89 | - | - | - | - | Upgrade
|
| Common Dividends Paid | -62.58 | -38.23 | -19.16 | -16.69 | -43.16 | -58.6 | Upgrade
|
| Other Financing Activities | 44.98 | 181.03 | 157.81 | 889 | -17.68 | -14.46 | Upgrade
|
| Financing Cash Flow | 1,171 | 711.83 | 4,613 | 2,666 | 4,414 | 593.58 | Upgrade
|
| Foreign Exchange Rate Adjustments | -20.84 | 7.55 | 92.27 | -23.23 | -45.77 | -4.06 | Upgrade
|
| Net Cash Flow | -1,667 | -2,219 | 2,492 | 119.61 | 2,171 | -1,550 | Upgrade
|
| Free Cash Flow | -2,303 | -2,838 | -2,170 | -1,507 | -2,037 | -2,042 | Upgrade
|
| Free Cash Flow Margin | -128.85% | -188.85% | -149.31% | -37.44% | -127.71% | -263.42% | Upgrade
|
| Free Cash Flow Per Share | -2.34 | -2.88 | -2.36 | -1.69 | -2.48 | -2.62 | Upgrade
|
| Cash Income Tax Paid | 79.01 | -65.42 | -261.57 | -43.19 | -25.64 | 35.33 | Upgrade
|
| Levered Free Cash Flow | -1,580 | -2,107 | -1,229 | -1,174 | -1,394 | -1,654 | Upgrade
|
| Unlevered Free Cash Flow | -1,553 | -2,089 | -1,210 | -1,160 | -1,375 | -1,646 | Upgrade
|
| Change in Net Working Capital | -119.51 | 64.96 | -527.02 | 263.06 | -83.95 | 354.09 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.